Background. The enzyme-linked immunoelectrotransfer blot (EITB) assay is the reference serological test for neurocysticercosis (NCC). A positive result on EITB does not always correlate with the presence of active infections in the central nervous system (CNS), and patients with a single viable brain cyst may be EITB negative. Nonetheless, EITB antibody banding patterns appears to be related with the expression of 3 protein families of Taenia solium, and in turn with the characteristics of NCC in the CNS (type, stage, and burden of viable cysts).
Neurocysticercosis (NCC) is a zoonosis of the human central nervous system (CNS) caused by the cysticercus of the pork tapeworm Taenia solium, and is the leading cause of late-onset epilepsy worldwide [1] [2] [3] [4] . Diagnosis of NCC is difficult. It depends on clinical and epidemiological criteria, supported by findings from neurologic imaging and serologic confirmation [5, 6] . Imaging constitutes the main diagnostic tool for physicians, allowing the recognition of cysticerci lodged in the brain, their type, stage, and number [3, 7, 8] . Magnetic resonance imaging (MRI) is more sensitive for diagnosing viable parenchymal and extraparenchymal NCC, whereas computed tomography (CT) is superior in detecting calcified lesions [7] . Imaging diagnosis is not always definitive. In some cases, images alone cannot differentiate NCC from other CNS lesions, and some NCC lesions may be missed on brain CT or MRI [9, 10] .
The enzyme-linked immunoelectrotransfer blot assay using lentil-lectin purified glycoprotein parasite antigens (LLGP-EITB) is the best available serological test for NCC [11] . In this assay, specific antibody bands reacting against 7 defined T. solium antigens (GP50, GP42-39, GP24, GP21, GP18, GP14, and GP13, named by their molecular weight in kilodaltons [kDa] ) are visually read, with high levels of specificity and sensitivity in patients with ≥2 viable brain cysts [11, 12] . Additionally, by detecting antibodies the EITB demonstrates evidence of exposure but not necessarily active infection. While the sensitivity of EITB is extremely high in patients with multiple viable lesions or extraparenchymal NCC, patients with a single brain lesion may have antibody responses not detectable by EITB and the antibody response may wane in patients with nonviable infections in the CNS, reducing the diagnostic capability of the EITB [13] [14] [15] .
In patients with symptomatic NCC looking for neurological care, EITB is usually a confirmatory tool supporting brain imaging findings for the diagnosis and follow-up of NCC patients [16, 17] . Additionally, the number of EITB antibody bands seen in clinical patients is greater than that observed in the general population [18, 19] . Nonetheless, the heterogeneity of EITB responses (expressed as antibody banding patterns) observed in clinical patients has not been studied in detail, nor how these banding patterns are related with the characteristics of NCC infection.
During the course of infection in the intermediate host, different sets of antigens of the T. solium cysticercus are expressed. These antigens demonstrate structural and functional differences and group into 3 protein families named as GP50 (comprised by the GP50 band alone), the T24-42 family (comprising the GP42-39 and GP24 bands) and the 8 kDa family (comprising the low molecular weight bands GP21, GP18, GP14, GP13, and eventually also found at the level of the GP24 band) [20] [21] [22] [23] . The patterns of EITB antibody bands in clinical patients with NCC are not random [23] , suggesting that their expression reflect the characteristics of the NCC in the host's CNS. We evaluated the relationship between EITB banding patterns with brain imaging findings of patients with NCC to demonstrate that the interpretation of their antibody banding patterns may supplement diagnostic imaging of NCC and contribute to its proper diagnosis.
MATERIALS AND METHODS

Samples and Study Design
Information regarding serological and brain image (CT and/or MRI) results, age, and sex from individuals with symptomatic NCC presenting for the first time to the Cysticercosis Unit at the Instituto Nacional de Ciencias Neurológicas in Lima, Peru, during a 6-year period (2009) (2010) (2011) (2012) (2013) (2014) (2015) were retrieved from our archives. Potential study subjects were selected if they had a NCC diagnosis based on brain images, regardless of their EITB results. Individuals with negative neuroimages were not included. Cases where the nearest serum sample was taken >90 days before or after an index brain image (the initial image in record for each patient) were also excluded to avoid the effects of disease evolution or treatment measures.
Enzyme-Linked Immunoelectrotransfer Blot Assay
The LLGP-EITB assay was performed as described by Tsang et al [11] . In brief, 7 glycoprotein antigens of the T. solium cysticercus (GP50, GP42-49, GP24, GP21, GP18, GP14, and GP13), obtained by separation and purification using sodium dodecyl sulphate-polyacrylamide gel electrophoresis, were transferred from the gels to nitrocellulose membranes and incubated in duplicate with pretreated serum samples, using 3.3ʹdiamin-obenzimidine tetrahydrochloride dihydrate as substrate for the visualization of bands (color development). Banding pattern readings were performed in 2 steps (a first reading is performed by the laboratory technician performing the assays, and then all results are revised by a supervisor. All dubious responses are selected for reprocessing, as well as a random 5% of all processed samples). Readers are blinded from imaging results to prevent any biases. The presence or absence of each of the 7 bands was recorded and coded to create the variable "EITB banding pattern, " as a chain of 7 consecutive 0 and 1 values indicating the absence or presence of each of the bands, respectively.
Images
Image readings were performed by a neuroradiologist external to the study and confirmed by neurologists on the study team. Radiological data (type, stage, and number of cysticerci) were collected. Extraparenchymal NCC was defined as the presence of ventricular and/or subarachnoid cysticerci. Intraparenchymal NCC was defined as the presence of live, viable, and/or degenerated cysticerci, with or without calcifications into the brain parenchyma. For the analyses, extraparenchymal NCC was the defining characteristic based on its strong serological response, thus mixed intra-and extraparenchymal infections were allocated into the extraparenchymal subgroup. Similarly, the presence of at least 1 live, viable cysticercus (with or without nonviable infection) classified the case as viable NCC. The number of live viable cysticerci was also recorded. Degenerated cysts and/or calcified lesions met criteria to be included in the nonviable subgroup.
Statistical Analysis
NCC patient characteristics were summarized using descriptive statistics. We performed a latent class analysis using the results of each of the 7 EITB bands (observed variables) to group banding patterns in homogeneous classes that represent different characteristics of CNS infection, in terms of the type, stage, and number of cysts (latent variable). Patients with unusual banding patterns (each representing <1% of the observed banding patterns in the study subjects) were excluded from the analysis to avoid their inclusion in classes as residuals. Five models with increasing numbers of classes (2-6) were fitted by maximum likelihood processes [24] . The optimal number of classes was established according to a statistical criterion (the model with the smallest Bayesian information criterion to account for model fit and parsimony [24] ) and interpretability of classes (distribution of representative banding patterns in each class). Once the optimal number of classes was established, 2 model parameters (class prevalences approximately ≥10% among classes and probabilities of bands conditional to class membership close to 0 or 1) were evaluated to confirm model structure [24] . Model stability was confirmed by random split-half reanalysis of the data (with and without patients with unusual banding patterns).
Bivariate associations between classes and age, sex, and imaging findings were performed using χ 2 and Kruskal-Wallis tests as required. The relationship between banding pattern classes (outcome variable) and brain imaging findings was assessed using multinomial logistic regression analyses. Three separate models for cyst type, cyst stage, and cyst burden (each adjusted by age and sex) were fitted and odds ratios (ORs) with 95% confidence intervals (CIs) for the presence of banding pattern classes were calculated. Statistical analyses were performed in R version 3.3.1, using the package poLCA for latent class analysis. P values < .05 were considered significant.
Ethical Considerations
This study was previously approved by the Institutional Review Board (IRB) of the Universidad Peruana Cayetano Heredia (approval number: 0006689). Anonymized archive sera samples and brain image information were evaluated, collected in prior IRB-approved studies with written informed consents specifically allowing future use of the collected samples.
RESULTS
There were 548 eligible cases during the study period. Sixteen (3%) of the study subjects had unusual banding patterns and were excluded from latent class analysis. A 4-class model was considered the optimal according to its smallest Bayesian information criterion compared with models of 2, 3, 5, and 6 classes (Supplementary Table 1 ). Representative banding patterns were also observed in each class (Table 1) . Class 1 (n = 75) included primarily patients EITB-negative (75%) or positive to the GP50 only, corresponding to the protein family of the same name. Class 2 (n = 142) included patients positive to bands GP42-39 and GP24 (related to the T24-42 protein family) with or without GP50. Class 3 (n = 51) and class 4 (n = 264) included patients who were positive to the high molecular weight bands (GP50, GP42-39, and GP24) similar to class 2, but in addition were also positive to the low molecular weight bands related to the 8 kDa protein family (GP21, GP18, GP14, and GP13). Classes 3 and 4 were defined as "positive" and "strongly positive" to antigens of the 8 kDa protein family according to the number of low molecular weight bands seen in each class (GP14 and GP13 in class 3, and GP14, GP13 and additionally GP21 and GP18 in class 4). Class prevalences were higher in classes 4 and 2 (50% and 27%, respectively) compared with classes 1 and 3 (14% and 9%, respectively). Probabilities of bands conditional to class membership were >80% for bands GP50, GP42-39, and GP24 in classes 2, 3, and 4 and >90% for bands GP21, GP18, GP14, and GP13 in class 4; the smallest conditional probability was observed for GP50 conditional to membership in class 1 (Supplementary Table 2 ). Model stability was confirmed with reanalysis using half of the data randomly selected, and banding pattern classes did not change when analyses included the 16 patients with unusual banding patterns (data not shown).
Bivariate analyses showed a strong association between antibody banding pattern classes and brain imaging findings (all P < .001; ). Distribution of banding pattern classes by age and sex showed older cases in classes 3 and 4 than those in classes 2 and 1 (P = .023), but there were no significant differences by sex. Extraparenchymal NCC cases were older than intraparenchymal NCC cases (P < .001); cases with nonviable and viable cysticerci were similar according to age, but different according to sex (67% of cases with nonviable infections were women; P = .001). Associations between banding pattern classes and brain imaging findings remained strong after adjustment by age and sex in the regression models, suggesting that type, stage, and number of lesions are the major drivers for banding pattern classes (Table 3 
DISCUSSION
Our study shows that the distribution of antibody banding patterns on LLGP-EITB is related to the type and characteristics of human NCC (type, stage, and number of cysts). Banding pattern classes representative of strong (classes 3 and 4) or weak (classes 1 and 2) antibody responses are more common in some NCC forms than others, and stronger antibody responses include those to smaller molecular weight antigens. This information may help to optimize the use of serological information in the diagnosis and follow-up of NCC patients.
We identified 4 clearly differentiated but internally homogeneous banding pattern classes. The distribution of EITB banding patterns in these classes (GP50 alone in class 1, GP42-39 and GP24 with or without GP50 in class 2, and all of these plus GP14 and GP13 in class 3 or GP21, GP18, GP14, and GP13 in class 4) strongly correlates with the distribution of these antigens in the 3 known protein families [20] [21] [22] [23] . Departing from reactions to the GP50 family in class 1, reactions to the T24-42 family add in class 2, and reactions to the antigens of the 8 kDa protein family are added in class 3 and class 4. Classes 3 and 4 include antibody responses to antigens of the same protein family. Class 4 shows a stronger antibody response compared to class 3 (a greater number of low molecular weight antibody bands was seen in class 4). Additionally, the inclusion of classes 3 and 4 as separate classes improves the interpretability of the remaining classes in the model (not seen in the models with 2, 3, 5, and 6 classes).
Age and sex did not strongly influence antibody banding class membership according to imaging findings in our study. We would have expected an older age in individuals in class 1 due to already resolved infections. However, negative or GP50-only reactions could also result from early infections in individuals with a single cyst, and these could have lowered the mean age in this class. The group of older, resolved cases was likely underrepresented in our sample of individuals attending a referral center by the first time.
Class 1 (EITB negative or positive to GP50) was related with nonviable infections or cases with a single viable intraparenchymal cysticercus. In this class, individuals positive to single band GP50 were similar to those EITB negative in terms of brain imaging findings. A few cases of apparent false positive reactions to GP50 have been also reported in the literature [25, 26] . Our data suggest that GP50 alone in the absence of other diagnostic bands is rarely associated with established infections with multiple cysts or extraparenchymal NCC.
Class 2 (positive to antigens of the T24-42 protein family with or without GP50) had combinations of the high molecular weight bands (GP50, GP42-39, and GP24), recognized as the most immunodominant in the EITB [11, 27, 28] . Antigens of the T24-42 family are recognized as tetraspanins [22] , membrane proteins involved in processes of cell proliferation, adhesion, motility, and scaffolding for the assembly of various complexes of proteins at the cell membrane [22, 29] . Due to their immunodominance, these banding patterns may persist in patients with nonviable NCC as observed in our study. Some patients in class 2 (corresponding to combinations of GP50, GP42-39, and GP24) had high-burden intraparenchymal infections as well as extraparenchymal infections, expected to express antigens from the 8 kDa protein family. As described by Hancock et al [22] , while most 8 kDa antigens migrate at the low molecular weight bands, some remain at the level of the GP24 band (belonging to class 2 in our analysis).
Classes 3 and 4 were strongly associated with extraparenchymal NCC as well as with intraparenchymal viable infections with a high cyst burden. Antigens belonging to the 8 kDa protein family (distributed in the bands GP21, GP18, GP14, and GP13 seen in classes 3 and 4) have been classified as excretory/secretory proteins associated with evasive immune responses [23, 30] . The presence of these bands has also been associated with a higher probability of viable cysticerci in the brain parenchyma in previous studies [11, 18] . Classes 3 and 4 are similar in structure, but they differ in the number of reactive low molecular weight antibody bands (stronger antibody responses to antigens of the 8 kDa protein family for class 4 compared with class 3).
Our study had some limitations to consider. Due to the crosssectional design, we cannot differentiate if the imaging findings on banding pattern classes corresponded to new or chronic infections. The exclusion of patients with no evidence of NCC on brain imaging limits our assessment to cases where lesions were apparent in neuroimaging and perhaps results in selection bias toward more evident infections. Data on prior antiparasitic treatment of patients were not available. Even when we only included the EITB results in sera of patients taken within 90 days before or after their initial brain image, it is possible that some patients had received antiparasitic therapy before attending our unit for first time and, as such, potential bias is possible due to the lack of control for this variable.
Additionally, the lack of covariates of clinical relevance (length of illness, symptoms, etc), could have resulted in a noncontrolled confounding effect. Nonetheless, clinical symptoms do not play too much of a role here, since calcified or degenerating cysts can be highly symptomatic in NCC cases, irrespective of the presence of viable cysts or antibody responses. Finally, the EITB provides a qualitative rather than a quantitative result, so further studies using quantitative methods, such as enzyme-linked immunosorbent assay and/or Luminex, could unveil other associations not detected here.
EITB banding patterns match quite well the heterogeneity of NCC brain imaging findings. Banding patterns of classes 3 and 4 (antibody responses to antigens of the 8 kDa protein family) are observed in highly antigenic infections (extraparenchymal NCC and intraparenchymal NCC with high cyst burden), whereas banding patterns of class 2 (antibody responses to antigens of the T24-42 protein family) are mostly observed in nonviable and viable intraparenchymal infections. Banding patterns of class 1 (negative or positive to the GP50 protein family) usually have intraparenchymal nonviable NCC or single viable cysticerci. The interpretation of the EITB banding patterns should provide valuable information for the diagnosis, characterization, and follow-up of NCC cases.
